<div id="readability-page-1"><p><span>UnitedHealth Group (NYSE:UNH - Get Free Report)</span> had its price target upped by investment analysts at Sanford C. Bernstein  from $379.00 to $433.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has an &#34;outperform&#34; rating on the healthcare conglomerate's stock. Sanford C. Bernstein's price objective would indicate a potential upside of 16.21% from the company's previous close.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>5 Stocks Congress Quietly Bought in Q3—Should You Follow?</li></ul><p>Several other equities research analysts have also recently issued reports on the stock. Baird R W cut shares of UnitedHealth Group from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report on Thursday, July 31st. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a &#34;buy&#34; rating in a research report on Tuesday, September 9th. KeyCorp lifted their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday. Weiss Ratings  reaffirmed a &#34;sell (d+)&#34; rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Finally, Morgan Stanley lifted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday, September 12th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned  a Hold rating and four have assigned  a Sell rating to the company. According to MarketBeat, the company  has a consensus rating of &#34;Hold&#34; and an average target price of $369.73.</p><p><b>Get Our Latest Stock Analysis on UnitedHealth Group</b></p><h2>UnitedHealth Group Trading Up 2.5%</h2><ul><li>5 Healthcare Plays Powering the Sector’s Big Comeback</li></ul><p>Shares of UNH traded up $8.94 during mid-day trading on Wednesday, hitting $372.60. The company had a trading volume of 3,677,904 shares, compared to its average volume of 12,711,535. The business's 50-day simple moving average is $311.44 and its 200-day simple moving average is $352.42. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market cap of $337.45 billion, a PE ratio of 16.16, a P/E/G ratio of 2.33 and a beta of 0.47. </p><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis.  UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts forecast that  UnitedHealth Group will post 29.54 earnings per share for the current year. </p><h2>Institutional Trading of UnitedHealth Group</h2><ul><li>More Than a Rebound: UnitedHealth Is Back in the Game</li></ul><p>Several institutional investors have recently added to or reduced their stakes in UNH. Norges Bank bought a new stake in  UnitedHealth Group during the second quarter valued at $3,837,207,000.  Nuveen LLC bought a new stake in  UnitedHealth Group during the first quarter valued at $3,846,764,000.  Vanguard Group Inc. grew its position in shares of  UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter.  Berkshire Hathaway Inc bought a new position in shares of  UnitedHealth Group during the second quarter worth about $1,572,193,000.  Finally, Dodge &amp; Cox grew its position in shares of  UnitedHealth Group by 117.7% during the second quarter. Dodge &amp; Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after acquiring an additional 4,730,192 shares during the last quarter. Institutional investors own  87.86% of the company's stock. </p><h2>UnitedHealth Group Company Profile</h2> (Get Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Read More</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>What is the S&amp;P/TSX Index?</li><li>Will Firefly’s $855M SciTec Acquisition Ignite a Stock Re-Rating?</li><li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion </li><li>Lithium Americas: Why This 31% Rally Is More Than Just a Headline</li><li>What is MarketRank™? How to Use it</li><li>Why Archer Aviation Stock Is Soaring—And What Comes Next</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Sanford C. Bernstein has raised its price target for UnitedHealth Group (NYSE:UNH) from $379.00 to $433.00, maintaining an "outperform" rating. This new target suggests a potential upside of 16.21% from the previous close. Other analysts have varied opinions, with some downgrading the stock while others have increased their price targets. Currently, the consensus rating is "Hold" with an average target price of $369.73. UnitedHealth Group's shares rose 2.5% to $372.60 during trading on Wednesday.</p>

Sanford C. Bernstein Increases UnitedHealth Group (NYSE:UNH) Price Target to $433.00